Why the study?
Do CGM metrics (TIR and GMI) predict serious CVD and mortality beyond HbA1c in patients with type 2 diabetes?
Population
1,363 participants with type 2 diabetes with 10-day continuous glucose monitoring (CGM) in the GRADE study
Comparison
CGM-derived time in range and glucose management… vs HbA1c
Design
Cohort
Follow-up
median 2.3 years
Authors
Loading...
CGM-derived GMI and HbA1c comparably predict cardiovascular and mortality outcomes in type 2 diabetes, but their prognostic values overlap and are not additive.
Do CGM metrics (TIR and GMI) predict serious CVD and mortality beyond HbA1c in patients with type 2 diabetes?
CGM-derived GMI and HbA1c comparably predict cardiovascular and mortality outcomes in type 2 diabetes, but their prognostic values overlap and are not additive.
TANG et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: